Percutaneous closure of patent ductus arteriosus: short term results
Objectives: To evaluate short term results of percutaneous patent ductus arteriosus (PDA) closure in a cohort of pediatric and adult patients following closure with the Amplatzer Ductal Occluder (ADO-1 and ADO-2) and Amplatzer Septal Occluder (ASO) devices. Study design: A total of 48 patients (1...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2013-06-01
|
Series: | Türk Kardiyoloji Derneği Arşivi |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-72693 |
id |
doaj-3ab0872696864c2bb9d10e98b893ddf8 |
---|---|
record_format |
Article |
spelling |
doaj-3ab0872696864c2bb9d10e98b893ddf82021-01-19T07:52:09ZengKARE PublishingTürk Kardiyoloji Derneği Arşivi1016-51692013-06-0141431031810.5543/tkda.2013.72693TKDA-72693Percutaneous closure of patent ductus arteriosus: short term resultsYüksel Kaya0Mustafa Orhan Bulut1Mustafa Yurtdaş2Ahmet Karakurt3Tolga Sinan Güvenç4Nihat Söylemez5Ahmet Güler6Edip Gönüllü7Yemlihan Ceylan8Ramazan Akdemir9Department Of Cardiology, Kafkas University, School Of Medicine, Kars, TurkeyDepartment Of Pediatric Cardiology, Van Women's And Chidren's Hospital, Van, TurkeyDepartment Of Cardiology, Private Lokman Hekim Van Hospital, Van, TurkeyDepartment Of Cardiology, Kafkas University, School Of Medicine, Kars, TurkeyDepartment Of Cardiology, Kafkas University, School Of Medicine, Kars, TurkeyDepartment Of Cardiology, Van Yüksek İhtisas Education And Research Hospital, Van, TurkeyDepartment Of Cardiology, Kafkas University, School Of Medicine, Kars, TurkeyDepartment Of Anestesiology And Reanimasyon, Van Education And Research Hospital, Van, TurkeyDepartment Of Cardiology, Yüksekova State Hospital, Hakkari, TurkeyDepartment Of Cardiology, Sakarya University, School Of Medicine, Sakarya, TurkeyObjectives: To evaluate short term results of percutaneous patent ductus arteriosus (PDA) closure in a cohort of pediatric and adult patients following closure with the Amplatzer Ductal Occluder (ADO-1 and ADO-2) and Amplatzer Septal Occluder (ASO) devices. Study design: A total of 48 patients (17 male and 31 female; range 3 to 39 years) were included in this study. All patients were evaluated with transthoracic echocardiography (TTE) before intervention. Percutaneous closure was performed under fluoroscopy through anterograde or retrograde route. Aortagraphy was performed to measure and classify the ductus arteriosus. Residual shunt through ductus was controlled by aortography at the tenth minute and by TTE 24 hours and three months after the procedure. Results: The released device was ADO-1 in 25 patients (51.2%), ADO-2 in 22 patients (45.8%), and ASO in one patient. Mean follow-up was 13.2 months. In 97.9% of patients, the occluder was placed into the ductus without any complication. In one patient, the device embolized to the left pulmonary artery during implantation. Aortography performed ten minutes after the procedure showed complete closure in 38 patients without residual defect. TTE revealed trace amounts of residual shunt within the device in two patients, flow around the device in two patients 24 hours after implantation, and residual shunt in only one patient three month after intervention. Conclusion: Transcatheter closure of PDA with ADO-1 and ADO-2 devices has low morbidity and mortality with high rates of success in selected patients.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-72693amplatzer occluder deviceductus arteriosuspatent/ therapy; echocardiography; heart catheterization; septal occluder device. |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yüksel Kaya Mustafa Orhan Bulut Mustafa Yurtdaş Ahmet Karakurt Tolga Sinan Güvenç Nihat Söylemez Ahmet Güler Edip Gönüllü Yemlihan Ceylan Ramazan Akdemir |
spellingShingle |
Yüksel Kaya Mustafa Orhan Bulut Mustafa Yurtdaş Ahmet Karakurt Tolga Sinan Güvenç Nihat Söylemez Ahmet Güler Edip Gönüllü Yemlihan Ceylan Ramazan Akdemir Percutaneous closure of patent ductus arteriosus: short term results Türk Kardiyoloji Derneği Arşivi amplatzer occluder device ductus arteriosus patent/ therapy; echocardiography; heart catheterization; septal occluder device. |
author_facet |
Yüksel Kaya Mustafa Orhan Bulut Mustafa Yurtdaş Ahmet Karakurt Tolga Sinan Güvenç Nihat Söylemez Ahmet Güler Edip Gönüllü Yemlihan Ceylan Ramazan Akdemir |
author_sort |
Yüksel Kaya |
title |
Percutaneous closure of patent ductus arteriosus: short term results |
title_short |
Percutaneous closure of patent ductus arteriosus: short term results |
title_full |
Percutaneous closure of patent ductus arteriosus: short term results |
title_fullStr |
Percutaneous closure of patent ductus arteriosus: short term results |
title_full_unstemmed |
Percutaneous closure of patent ductus arteriosus: short term results |
title_sort |
percutaneous closure of patent ductus arteriosus: short term results |
publisher |
KARE Publishing |
series |
Türk Kardiyoloji Derneği Arşivi |
issn |
1016-5169 |
publishDate |
2013-06-01 |
description |
Objectives: To evaluate short term results of percutaneous patent ductus arteriosus (PDA) closure in a cohort of pediatric and adult patients following closure with the Amplatzer Ductal Occluder (ADO-1 and ADO-2) and Amplatzer Septal Occluder (ASO) devices.
Study design: A total of 48 patients (17 male and 31 female; range 3 to 39 years) were included in this study. All patients were evaluated with transthoracic echocardiography (TTE) before intervention. Percutaneous closure was performed under fluoroscopy through anterograde or retrograde route. Aortagraphy was performed to measure and classify the ductus arteriosus. Residual shunt through ductus was controlled by aortography at the tenth minute and by TTE 24 hours and three months after the procedure.
Results: The released device was ADO-1 in 25 patients (51.2%), ADO-2 in 22 patients (45.8%), and ASO in one patient. Mean follow-up was 13.2 months. In 97.9% of patients, the occluder was placed into the ductus without any complication. In one patient, the device embolized to the left pulmonary artery during implantation. Aortography performed ten minutes after the procedure showed complete closure in 38 patients without residual defect. TTE revealed trace amounts of residual shunt within the device in two patients, flow around the device in two patients 24 hours after implantation, and residual shunt in only one patient three month after intervention.
Conclusion: Transcatheter closure of PDA with ADO-1 and ADO-2 devices has low morbidity and mortality with high rates of success in selected patients. |
topic |
amplatzer occluder device ductus arteriosus patent/ therapy; echocardiography; heart catheterization; septal occluder device. |
url |
https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-72693 |
work_keys_str_mv |
AT yukselkaya percutaneousclosureofpatentductusarteriosusshorttermresults AT mustafaorhanbulut percutaneousclosureofpatentductusarteriosusshorttermresults AT mustafayurtdas percutaneousclosureofpatentductusarteriosusshorttermresults AT ahmetkarakurt percutaneousclosureofpatentductusarteriosusshorttermresults AT tolgasinanguvenc percutaneousclosureofpatentductusarteriosusshorttermresults AT nihatsoylemez percutaneousclosureofpatentductusarteriosusshorttermresults AT ahmetguler percutaneousclosureofpatentductusarteriosusshorttermresults AT edipgonullu percutaneousclosureofpatentductusarteriosusshorttermresults AT yemlihanceylan percutaneousclosureofpatentductusarteriosusshorttermresults AT ramazanakdemir percutaneousclosureofpatentductusarteriosusshorttermresults |
_version_ |
1724332142924660736 |